Latest Oncotype DX Stories
Positive Results of Largest Genomic Study in DCIS Reconfirm Oncotype DX is a Strong, Independent Predictor of Local Recurrence SAN ANTONIO, Dec.
Presentations at SABCS and SUO Reveal Company's Ability to Detect Breast and Bladder Cancers in Blood and Urine, Respectively SAN ANTONIO, Dec.
Studies Presented at the 2014 Society of Urologic Oncology Annual Meeting Demonstrate Test's Value to Physicians and Patients, Support Increased Adoption and Reimbursement REDWOOD
Test Tailors Cancer Treatment Plan, Improves Outcomes and Lowers Chemo Costs Franklin, Tennessee (PRWEB) December 02, 2014 DiaTech Oncology, provider
Landmark Study Reconfirms Oncotype DX® Stratifies DCIS Patient Risk REDWOOD CITY, Calif., Dec. 2, 2014 /PRNewswire/ -- Genomic Health, Inc.
REDWOOD CITY, Calif., Nov. 26, 2014 /PRNewswire/ -- Genomic Health, Inc.
These Studies and Genomic Health's First Liquid Biopsy Study in Bladder Cancer To Be Presented at 2014 Society of Urologic Oncology Annual Meeting, December 3-5 REDWOOD CITY, Calif., Nov.
9% Increase in Test Volume; 5% Increase in Total Revenue REDWOOD CITY, Calif., Nov.
REDWOOD CITY, Calif., Nov. 4, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that
REDWOOD CITY, Calif., Oct. 28, 2014 /PRNewswire/ -- Genomic Health, Inc.
- an ornament or knob in the shape of a flower
- In architecture, a floral ornament; specifically, the large conventional flower usually placed in the center of the abacus of a Corinthian capital or classic ceiling-caisson; also, the floreated termination of a Gothic finial.